Cell surface glycans: The why and how of their functionality as biochemical signals in lectin-mediated information transfer

Critical Reviews in Immunology

Volumn 26, Issue 1, 2006, Pages 43-79

  Gabius, Hans Joachim ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apoptosis; Cell adhesion; Galectin; Glycosylation; Glycosyltransferases; Integrin; Phagocytosis

Indexed keywords

CELL SURFACE PROTEIN; GALECTIN; GLYCAN; GLYCOSYLTRANSFERASE; INTEGRIN; LECTIN;

APOPTOSIS; CELL ADHESION; CELL INTERACTION; CELL SURFACE; EFFECTOR CELL; GLYCOSYLATION; HUMAN; IMMUNOREGULATION; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL MEMBRANE; DRUG DESIGN; HUMANS; LECTINS; MACROMOLECULAR SUBSTANCES; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; SIGNAL TRANSDUCTION;

EID: 33646879955     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (330)

1. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem. 1985;54:631-64.
2. Kobata A. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem. 1992;209:483-501.
3. Sharon N, Lis H. Glycoproteins: structure and function. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 133-62.
4. Reuter G, Gabius H-J. Eukaryotic glycosylation - whim of nature or multipurpose tool? Cell Mol Life Sci. 1999;55:368-422.
5. Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 2002;12:43R-56R.
6. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta. 1999;1473:4-8.
7. Hart GW, Haltiwanger RS, Holt GD, Kelly WG. Glycosylation in the nucleus and cytoplasm. Annu Rev Biochem. 1989;58:841-74.
8. Wells L, Hart GW. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett. 2003;546:154-8.
9. Schirmer J, Aktories K. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim Biophys Acta. 2004;1673:66-74.
10. Vliegenthart JFG, Casset F. Novel forms of protein glycosylation. Curr Opin Struct Biol. 1998;8:565-71.
11. Furmanek A, Hofsteenge J. Protein C-mannosylation: facts and questions. Acta Biochim Pol. 2000;47:781-9.
12. Gonzales de Peredo A, Klein D, Macek B, Hess D, Peter-Katalinic J, Hofsteenge J. C-Mannosylation and O-fucosylation of thrombospondin. Mol Cell Proteomics. 2002;1:11-8.
13. Okajima T, Irvine KD. Regulation of Notch signaling by O-linked fucose. Cell. 2002;111:893-904.
14. Haines N, Irvine KD. Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol. 2003;4:786-97.
15. Shao L, Haltiwanger RS. O-Fucose modifications of epidermal growth factor-like repeats and thrombospondin type 1 repeats: unusual modifications in unusual places. Cell Mol Life Sci. 2003;60:241-50.
16. Shi S, Stanley P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc Natl Acad Sci U S A. 2003;100:5234-9.
17. Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, Wilson R, Wang Y, Stanley P, Irvine KD, Haltiwanger RS, Vogt TF. Fringe is a glycosyltransferase that modifies Notch. Nature. 2000;406:369-75.
18. Hounsell EF, Davies MJ, Renouf DV. O-Linked protein glycosylation structure and function. Glycoconjugate J. 1996;13:19-26.
19. Reuter G, Gabius H-J. Sialic acids. Structure, analysis, metabolism, and recognition. Biol Chem Hoppe-Seyler. 1996;377:325-42.
20. Tsuboi S, Fukuda M. Roles of O-linked oligosaccharides in immune responses. BioEssays. 2001;23:43-53.
21. Hang HC, Bertozzi CR. The chemistry and biology of mucin-type O-linked glycosylation. Bioorg Med Chem. 2005;13:5021-34.
22. Shakin-Eshleman SH. Regulation of N-linked core glycosylation. Trends Glycosci Glycotechnol. 1996;8:115-30.
23. Ben-Dor S, Esterman N, Rubin E, Sharon N. Biases and complex patterns in the residues flanking protein N-glycosylation sites. Glycobiology. 2004;14:95-101.
24. Petrescu A-J, Milac A-L, Petrescu SM, Dwek RA, Wormald MR. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology. 2004;14:103-14.
25. Kopitz J. Glycolipids: structure and function. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives, London (UK)/Weinheim (Germany): Chapman & Hall; p. 163-89.
26. Winterburn PJ, Phelps CF. The significance of glycosylated proteins. Nature. 1972;236:147-51.
27. Sharon N. Lectins: from obscurity into the limelight. Protein Sci. 1998;7:2042-8.
28. Rüdiger H, Siebert H-C, Solís D, Jiménez-Barbero J, Romero A, von der Lieth C-W, Díaz-Mauriño T, Gabius H-J. Medicinal chemistry based on the sugar code: fundamentals of lectinology and experimental strategies with lectins as targets. Curr Med Chem. 2000;7:389-416.
29. de Lederkremer RM, Colli W. Galactofuranose-containing glycoconjugates in trypanosamatids. Glycobiology. 2003;1995:547-52.
30. Pedersen LL, Turco LJ. Galactofuranose metabolism: a potential target for antimicrobial chemotherapy. Cell Mol Life Sci. 2003;60:259-66.
31. Laine RA. The information-storing potential of the sugar code. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives, London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 1-14.
32. Szathmáry E. Why are there four letters in the genetic alphabet? Nat Rev Genet. 2003;4:995-1001.
33. Brockhausen I, Schachter H. Glycosyltransferases involved in N- and O-glycan biosynthesis. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 79-113.
34. Gabius H-J, André S, Kaltner H, Siebert H-C. The sugar code: functional lectinomics. Biochim Biophys Acta. 2002;1572:165-77.
35. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi M-A, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie. 2001;83:727-37.
36. Kaneko M, Nishihira S, Narimatsu H, Saitou N. The evolutionary history of glycosyltransferase genes. Trends Glycosci Glycotechnol. 2001;13:147-55.
37. Hennet T. The galactosyltransferase family. Cell Mol Life Sci. 2002;59:1081-95.
38. Martinez-Duncker I, Mollicone R, Candelier J-J, Breton C, Oriol R. A new superfamily of protein-O-fucosyltransferases, α2-fucosyltransferases, and α6-fucosyltransferases: phylogeny and identification of conserved peptide motifs. Glycobiology. 2003;13:1C-5C.
39. Ten Hagen KG, Fritz TA, Tabak LA. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. Glycobiology. 2003;13:1R-16R.
40. Harduin-Lepers A, Mollicone R, Delannoy P, Oriol R. The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology. 2005;15:805-17.
41. Young WW Jr, Holcomb DR, Ten Hagen KG, Tabak LA. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family. Glycobiology. 2003;13:549-57.
42. Cheng L, Tachibana K, Iwasaki H, Kameyama A, Zhang Y, Kubota T, Hiruma T, Tachibana K, Kudo T, Guo J-M, Narimatsu H. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15. FEBS Lett. 2004;566:17-24.
43. Schwientek T, Yeh JC, Levery SB, Keck B, Merkx G, van Kessel AG, Fukuda M, Clausen H. Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus associated core 2 β1,6-N- acetylglucosaminyltransferase. J Biol Chem. 2000;275:11106-13.
44. Hemmerich S, Verdugo D, Rath VL. Strategies for drug discovery by targeting sulfation pathways. Drug Discov Today. 2004;9:967-75.
45. Kikuchi J, Shindohara H, Nonomura C, Ando H, Takaku S, Nojiri H, Nakamura M. Not core 2 β1,6-N-acetylglucosaminyltransferase-2 or -3 but -1 regulates sialyl-Lewis x expression in human precursor B cells. Glycobiology. 2005;15:271-80.
46. Martinez M, Joffraud M, Giraud S, Baisse B, Bernimoulin MP, Schapira M, Spertini O. Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII. J Biol Chem. 2005;280:5378-90.
47. Merzaban JS, Zuccolo J, Corbel SY, Williams MJ, Ziltener HJ. An alternate core 2 β1,6-N-acetylglucosaminyltransferase selectively contributes to P-selectin ligand formation in activated CD8 T cells. J Immunol. 2005;174:4051-9.
48. Yan A, Lennarz WJ. Unraveling the mechanism of protein N-glycosylation. J Biol Chem. 2005;280:3121-4.
49. Pavelka M. Topology of glycosylation - a histochemist's view. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 115-20.
50. Akasaka-Manya K, Manya H, Kobayashi K, Toda T, Endo T. Structure-function analysis of human protein O-linked mannose β1,2-N- acetylglucosaminyltransferase 1, POMGnT1. Biochem Biophys Res Commun. 2004;320:39-44.
51. Kresse H. Proteoglycans: structure and functions. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 201-22.
52. Yanagishita M, Ishihara M, editors. Diverse functions and structures on heparan sulfate proteoglycan. Trends Glycosci Glycotechnol. 1998;10:51-233.
53. Coombe DR, Kett WC. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci. 2005;62:410-24.
54. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu Rev Biochem. 2005;74:385-410.
55. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed. 2002;41:390-412.
56. Casu B, Petitou M, Provasoli M, Sinay P. Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci. 1988;13:221-5.
57. Selleck SB. Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. Trends Genet. 2000;16:206-12.
58. Turnbull J, Powell A, Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 2001;11:75-82.
59. Brockhausen I, Schutzbach J, Kuhns W. Glycoproteins and their relationship to human disease. Acta Anat. 1998;161:36-78.
60. Schachter H, editor. Molecular basis of glycoconjugate disease. Biochim Biophys Acta. 1999;1455:61-418.
61. Muramatsu T. Essential roles of carbohydrate signals in development, immune response and tissue functions, as revealed by gene targeting. J Biochem. 2000;127:171-6.
62. Furukawa K, Takamiya K, Okada M, Inoue M, Fukumoto S. Novel functions of complex carbohydrates elucidated by the mutant mice of glycosyltransferase genes. Biochim Biophys Acta. 2001;1525:1-12.
63. Lowe JJ, Marth JD. A genetic approach to mammalian glycan function. Annu Rev Biochem. 2003;72:643-91.
64. Haltiwanger RS, Lowe JB. Role of glycosylation in development. Annu Rev Biochem. 2004;73:491-537.
65. Lee J-S, Chien C-B. When sugars guide axons: insights from heparan sulphate proteoglycan mutants. Nat Rev Genet. 2004;5:923-35.
66. Hooper LV, Manzella SM, Baenziger JU. The biology of sulfated oligosaccharides. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 261-76.
67. Grunwell JR, Bertozzi CR. Carbohydrate sulfotransferases of the GalNAc/Gal/GlcNAc6ST family. Biochemistry. 2002;41:13117-26.
68. Varki A, Hooshmand F, Diaz S, Varki NM, Hedrick SM. Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetyltransferase. Cell. 1991;65:65-74.
69. Siebert H-C, Lü SY, Frank M, Kramer J, Wechselberger R, Joosten J, André S, Rittenhouse-Olson K, Roy R, von der Lieth C-W, Kaptein R, Vliegenthart JFG, Heck AJR, Gabius H-J. Analysis of protein-carbohydrate interaction at the lower size limit of the protein part (15-mer peptide) by NMR spectroscopy, electrospray ionization mass spectrometry, and molecular modeling. Biochemistry. 2002;41:9707-17.
70. 1 as a ligand: identification of the binding strategies of three 15mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin. Chem Eur J. 2006;12:388-402.
71. Bojarski AJ, Nowak M, Testa B. Conformational constraints on side chains in protein residues increase their information content. Cell Mol Life Sci. 2003;60:2526-31.
72. Carver JP. Oligosaccharides: how can flexible molecules act as signals? Pure Appl Chem. 1993;65:763-70.
73. Gabius H-J. The how and why of protein-carbohydrate interaction: a primer to the theoretical concept and a guide to application in drug design. Pharmaceut Res. 1998;15:23-30.
74. Solís D, Jiménez-Barbero J, Kaltner H, Romero A, Siebert H-C, von der Lieth C-W, Gabius H-J. Towards defining the role of glycans as hardware in information storage and transfer: basic principles, experimental approaches and recent progress. Cells Tissues Organs. 2001;168:5-23.
75. Gabius H-J, Siebert H-C, André S, Jiménez-Barbero J, Rüdiger H. Chemical biology of the sugar code. ChemBioChem. 2004;5:740-64.
76. Asensio JL, Espinosa JF, Dietrich H, Cañada FJ, Schmidt RR, Martín-Lomas M, André S, Gabius H-J, Jiménez-Barbero J. Bovine heart galectin-1 selects a distinct (syn) conformation of C-lactose, a flexible lactose analogue. J Am Chem Soc. 1999;121:8995-9000.
77. Siebert H-C, Jiménez-Barbero J, André S, Kaltner H, Gabius H-J. Describing the topology of the bound ligand by transferred NOE spectroscopy and molecular modeling. Methods Enzymol. 2003;362:417-34.
78. Hardy BJ. The glycosidic linkage flexibility and time-scale similarity hypotheses. J Mol Struct. 1997;395-396:187-200.
79. Fischer E. Einfluss der Configuration auf die Wirkung der Enzyme. Ber Dt Chem Ges. 1894;27:2985-93.
80. Watkins WM, Morgan WTJ. Neutralisation of the anti-H agglutinin in eel serum by simple sugars. Nature. 1952;169:825-6.
81. Nowell PC. Phytohemagglutinin: an inhibitor of mitosis in cultures of normal human leukocytes. Cancer Res. 1960;20:462-6.
82. Kilpatrick DC, Green C. Lectins as blood typing reagents. Adv Lectin Res. 1992;5:51-94.
83. Watkins WM. A half century of blood-group antigen research: some personal recollections. Trends Glycosci Glycotechnol. 1999;11:391-411.
84. Rüdiger H, Gabius H-J. Plant lectins: occurrence, biochemistry, functions and applications. Glycoconjugate J. 2001;18:589-613.
85. Boyd WC. The proteins of immune reactions. In: Neurath H, Bailey K, editors. The proteins, Vol. 2, Part 2. New York: Academic Press; 1954. p. 756-844.
86. Mitchell SW. Researches upon the venom of the rattlesnake. Smithsonian Contributions to Knowledge. 1860;XII:89-90.
87. Ogilvie ML, Gartner TK. Identification of snake venoms. J Herpetol. 1984;18:285-90.
88. Gabius H-J. Glycohistochemistry: the why and how of detection and localization of endogenous lectins. Anat Histol Embryol. 2001;30:3-31.
89. Sharon N, Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology. 2004;14:53R-62R.
90. Morell AG, Irvine RA, Sternlieb I, Scheinberg IH, Ashwell G. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem. 1968;243:155-9.
91. Hudgin RL, Pricer WEJ, Ashwell G, Stockert RJ, Morell AG. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J Biol Chem. 1974;249:5536-43.
92. Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem. 1982;51:531-54.
93. Gabius H-J. Detection and functions of mammalian lectins - with emphasis on membrane lectins. Biochim Biophys Acta. 1991;1071:1-18.
94. Rice KG. Glycoconjugate-mediated drug targeting. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 471-83.
95. Yamazaki N, Kojima S, Bovin NV, André S, Gabius S, Gabius H-J. Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev. 2000;43:225-44.
96. Weigel PH, Yik JHN. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/ chondroitin sulfate receptors. Biochim Biophys Acta. 2002;1572:341-2.
97. Göbel WF, Avery OT. Chemo-immunological studies on conjugated carbohydrate-proteins. I. The synthesis of p-aminophenyl β-glucoside, p-aminophenyl β-galactoside, and their coupling with serum globulin. J Exp Med. 1929;50:521-31.
98. Avery OT, Göbel WF. Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-protein antigens. J Exp Med. 1929;50:533-50.
99. Gabius H-J, Gabius S. Chemical and biochemical strategies for the preparation of glycohistochemical probes and their application in lectinology. Adv Lectin Res. 1992;5:123-57.
100. Gabius H-J, Gabius S, Zemlyanukhina TV, Bovin NV, Brinck U, Danguy A, Joshi SS, Kayser K, Schottelius J, Sinowatz F, Tietze LF, Vidal-Vanaclocha F, Zanetta J-P. Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. Histol Histopathol7. 1993;8:369-83.
101. Lee YC, Lee RT, editors. Neoglycoconjugates. Preparation and applications. San Diego: Academic Press; 1994.
102. Drickamer K, Dodd RB. C-type lectin-like domains in Caenorhabditis elegans: predictions from the complete genome sequence. Glycobiology. 1999;9:1357-69.
103. Miller ME, Seals J, Kaye R, Levitsky LC. A familial, plasma-associated defect of phagocytosis: a new cause of recurrent bacterial infections. Lancet. 1968;11:60-2.
104. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature. 1983;304:30-4.
105. Gabius H-J. Animal lectins. Eur J Biochem. 1997;243:543-76.
106. Angata T, Brinkman-van der Linden ECM. I-type lectins. Biochim Biophys Acta. 2002;1572:294-316.
107. Bianchet MA, Odom EW, Vasta GR, Amzel LM. A novel fucose recognition fold involved in innate immunity. Nat Struct Biol. 2002;9:628-34.
108. Dahms NM, Hancock MK. P-type lectins. Biochim Biophys Acta. 2002;1572:317-40.
109. Kawabata S-I, Tsuda R. Molecular basis of non-self recognition by the horseshoe crab tachylectins. Biochim Biophys Acta. 2002;1572:414-21.
110. Loris R. Principles of structures of animal and plant lectins. Biochim Biophys Acta. 2002;1572:198-208.
111. Ebner S, Sharon N, Ben-Tal N. Evolutionary analysis reveals collective properties and specificity in the C-type lectin and lectin-like domain superfamily. PROTEINS. 2003;52:44-55.
112. Tsuji S, Uehori J, Matsumoto M, Suzuki J, Mutsuhisa A, Toyoshima K, Seya T. Human intelectin is a novel lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem. 2001;276:23456-63.
113. Palaniyar N, Nedesalingam J, Clark H, Shih MJ, Dodds AW, Reid KBM. Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin. J Biol Chem. 2004;279:32728-36.
114. Gabius H-J, Engelhardt R, Rehm S, Cramer F. Biochemical characterization of endogenous carbohydrate-binding proteins from spontaneous murine rhabdomyosarcoma, mammary adenocarcinoma, and ovarian teratoma. J Natl Cancer Inst. 1984;73:1349-57.
115. Gabius H-J, Brehler R, Schauer A, Cramer F. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virch Arch [Cell Pathol]. 1986;52:107-15.
116. Gabius H-J. Concepts of tumor lectinology. Cancer Investig. 1997;15:454-64.
117. Ohannesian DW, Lotan R. Galectins in tumor cells. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 459-69.
118. Lahm H, André S, Höflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius H-J. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol. 2001;127:375-86.
119. Cooper DNW. Galectinomics: finding themes in complexity. Biochim Biophys Acta. 2002;1572:209-31.
120. Lahm H, André S, Hoeflich A, Kaltner H, Siebert H, Sordat B, von der Lieth C-W, Wolf E, Gabius H-J. Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconjugate J. 2004;20:227-38.
121. Danguy A, Rorive S, Decaestecker C, Bronckart Y, Kaltner H, Hadari YR, Goren R, Zick Y, Pétein M, Salmon I, Gabius H-J, Kiss R. Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol. 2001;16:861-8.
122. Saal I, Nagy N, Lensch M, Lohr M, Manning JC, Decaestecker C, André S, Kiss R, Salmon I, Gabius H-J. Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histol Histopathol. 2005;20:1191-208.
123. Camby I, Decaestecker C, Lefranc F, Kaltner H, Gabius H-J, Kiss R. Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern. Biochem Biophys Res Commun. 2005;335:27-35.
124. Delorge S, Saussez S, Pelc P, Devroede B, Marchant H, Burchert M, Zeng F-Y, Danguy A, Salmon I, Gabius H-J, Kiss R. Correlation of galectin-3/galectin- 3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg. 2000;122:834-41.
125. Camby I, Belot N, Rorive S, Lefranc F, Maurage C-A, Lahm H, Kaltner H, Hadari YR, Ruchoux M-M, Brotchi J, Zick Y, Salmon I, Gabius H-J, Kiss R. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol. 2001;11:12-26.
126. Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius H-J, Kiss R. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol. 2002;61:585-96.
127. Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector J-C, Zick Y, Salmon I, Danguy A, Kiss R, Gabius H-J. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut. 2002;50:392-401.
128. Kayser K, Höft D, Hufnagl P, Caselitz J, Zick Y, André S, Kaltner H, Gabius H-J. Combined analysis of tumor growth pattern and expression of endogenous lectins as a prognostic tool in primary testicular cancer and its lung metastases. Histol Histopathol. 2003;18:771-9.
129. Kayser K, Nwoye JO, Kosjerina S, Goldmann T, Vollmer E, Kaltner H, André S, Gabius H-J. Atypical adenomatous hyperplasia of lung: its incidence and analysis of clinical, glycohistochemical and structural features including newly defined growth regulators and vascularization. Lung Cancer. 2003;42:171-82.
130. Nagy N, Legendre H, Engels O, André S, Kaltner H, Wasano K, Zick Y, Pector J-C, Decaestecker C, Gabius H-J, Salmon I, Kiss R. Refined prognostic evaluation in colon cancer using immunohistochemical galectin fingerprinting. Cancer. 2003;97:1849-58.
131. Lefranc F, Mijatovic T, Decaestecker C, Kaltner H, André S, Brotchi J, Salmon I, Gabius H-J, Kiss R. Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to surrounding tissue and their contribution to prognosis. Neurosurgery. 2005;56:763-76.
132. Stillman BN, Mischel PS, Baum LG. New roles for galectins in brain tumors: from prognostic markers to therapeutic targets. Brain Pathol. 2005;15:124-32.
133. Kayser K, Gabius H-J. Graph theory and the entropy concept in histochemistry. Theoretical considerations, application in histopathology and the combination with receptor-specific approaches. Progr Histochem Cytochem. 1997;32(2):1-106.
134. Kayser K, Gabius H-J. The application of thermodynamic principles to histochemical and morphometric tissue research: principles and practical outline with focus on glycosciences. Cell Tissue Res. 1999;296:443-55.
135. Gabius H-J, Kohnke-Godt B, Leichsenring M, Bardosi A. Heparin-binding lectin of human placenta as a tool for histochemical ligand localization and ligand isolation. J Histochem Cytochem. 1991;39:1249-56.
136. Gabius H-J, Wosgien B, Hendrys M, Bardosi A. Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody. Histochemistry. 1991;95:269-77.
137. Purkrábková T, Smetana K Jr, Dvoránková B, Holíková Z, Böck C, Lensch M, André S, Pytlík R, Liu F-T, Klíma J, Smetana K, Motlik J, Gabius H-J. New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol Cell. 2003;95:535-45.
138. Plzák J, Betka J, Smetana K Jr, Chovanec M, Kaltner H, André S, Kodet R, Gabius H-J. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma. Eur J Cancer. 2004;40:2324-30.
139. Boraston AB, Bolam DN, Gilbert H-J, Davies GJ. Carbohydrate-binding modules: fine-tuning polysaccharide recognition. Biochem J. 2004;382:769-81.
140. Cummings RD. Lectins as tools for glycoconjugate purification and characterization. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 191-9.
141. Manning JC, Seyrek K, Kaltner H, André S, Sinowatz F, Gabius H-J. Glycomic profiling of developmental changes in bovine testis by lectin histochemistry and further analysis of the most prominent alteration on the level of the glycoproteome by lectin blotting and lectin affinity chromatography. Histol Histopathol. 2004;19:1043-60.
142. n epitope. J Biol Chem. 2000;275:8625-32.
143. x and PSGL-1. Cell. 2000;103:467-79.
144. Ahmad N, Gabius H-J, Kaltner H, André S, Kuwabara I, Liu F-T, Oscarson S, Norberg T, Brewer CF. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectin-1, -3 and -7. Evidence for differential binding specificities. Can J Chem. 2002;80:1096-104.
145. Guo Y, Feinberg H, Conroy E, Mitchell DA, Alvarez R, Blixt O, Taylor ME, Weis WI, Drickamer K. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol. 2004;11:591-8.
146. X trisaccharide and Schistosoma mansoni egg antigens. J Biol Chem. 2004;279:33161-7.
147. Shin SW, Park SS, Park DS, Kim MG, Kim SC, Brey PT, Park HY. Isolation and characterization of immune-related genes from the fall webworm, Hyphantria cunea, using PCR-based differential display and subtractive cloning. Insect Biochem Mol Biol. 1998;28:827-37.
148. Koizumi N, Imamura M, Kadotani T, Yaoi K, Iwahana H, Sato R. The lipopolysaccharide-binding protein participating in hemocyte nodule formation in the silkworm Bombyx mori is a novel member of the C-type lectin superfamily with two different tandem carbohydrate-recognition domains. FEBS Lett. 1999;443:139-43.
149. Yu X-Q, Gan H, Kanost MR. Immulectin, an inducible C-type lectin from an insect, Manduca sexta, stimulates activation of plasma prophenol oxidase. Insect Biochem Mol Biol. 1999;29:585-97.
150. Yu X-Q, Kanost MR. Immulectin-2, a lipopolysaccharide-specific lectin from an insect, Manduca sexta, is induced in response to Gram-negative bacteria. J Biol Chem. 2000;275:37373-81.
151. Yu X-Q, Tracy ME, Ling E, Scholz FR, Trenczek T. A novel C-type immulectin-3 from Manduca sexta is translocated from hemolymph into the cytoplasm of hemocytes. Insect Biochem Mol Biol. 2005;35:285-95.
152. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius H-J. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem. 2001;276:35917-23.
153. - leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia. 2002;16:840-5.
154. Fukumori T, Takenaka Y, Yoshii T, Kim H-RC, Hogan V, Inohara H, Kagawa S, Raz A. CD29 and CD7 mediate galectin-3-induced type II T cell apoptosis. Cancer Res. 2003;63:8202-11.
155. Kopitz J, André S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu F-T, Cantz M, Heck AJR, Gabius H-J. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene. 2003;22:6277-88.
156. Ahmad N, Gabius H-J, André S, Kaltner H, Sabesan S, Liu B, Macaluso F, Brewer CF. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem. 2004;279:10841-7.
157. Sturm A, Lensch M, André S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU, Gabius H-J. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol. 2004;173:3825-37.
158. 1 in silico and in vitro on human neuroblastoma cells. Int J Cancer. 2005;114:46-57.
159. Tsuchiyama Y, Wada J, Zhang H, Morita Y, Hiragushi K, Hida K, Shikata K, Yamamura M, Kanwar YS, Makino H. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int. 2000;58:1941-52.
160. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol. 2002;170:3631-6.
161. Vitale C, Romagnani C, Puccetti A, Olive D, Costello R, Chiossone L, Pitto A, Bacigalupo A, Moretta L, Mingari MC. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells. Proc Natl Acad Sci U S A. 2001;98:5764-9.
162. Nutku E, Aizawa H, Hudson SA, Bochner BS. Ligation of siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood. 2003;101:5014-20.
163. Von Gunten S, Yousefi S, Seitz M, Jakob SM, Schaffner T, Seger R, Takala J, Villiger PM, Simon H-U. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood. 2005;106:1423-31.
164. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta. 2002;1572:401-13.
165. Lu J, Teh C, Kishore U, Reid KBM. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta. 2002;1572:387-400.
166. Van de Wetering JK, van Golde LMG, Batenburg JJ. Collectins: players of the innate immune system. Eur J Biochem. 2004;271:1229-49.
167. Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin: a soluble pattern recognition molecule. Mol Immunol. 2004;41:113-21.
168. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J. 2005;35:548-55.
169. Muto S, Takada T, Matsumoto K. Biological activities of human mannose-binding lectin bound to two different ligand sugar structures, Lewis A and Lewis B antigens and high-mannose-type oligosaccharides. Biochim Biophys Acta. 2001;1527:39-46.
170. Terada M, Khoo KH, Inoue R, Chen CI, Yamada K, Sakaguchi H, Kadowaki N, Ma BY, Oka S, Kawasaki T, Kawasaki N. Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N-glycan. J Biol Chem. 2005;280:10897-913.
171. Fujita T, Matsushita M, Endo Y. The lectin-complement pathway: its role in innate immunity and evolution. Immunol Rev. 2004;198:185-202.
172. Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem. 2001;276:28939-45.
173. Bernhard OK, Lai J, Wilkinson J, Sheil MM, Cunningham AL. Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4. J Biol Chem. 2004;279:51828-35.
174. Snyder GA, Colonna M, Sun PD. The structure of DC-SIGNR with a portion of its repeat domain lends insights to modeling of the receptor tetramer. J Mol Biol. 2005;347:979-89.
175. André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius H-J. Galectins-1 and -3 and their ligands in tumor biology. J Cancer Res Clin Oncol. 1999;125:461-74.
176. Feinberg H, Guo Y, Mitchell DA, Drickamer K, Weis WI. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem. 2005;280:1327-35.
177. Van Gisbergen KPJM, Aarnoudse CA, Meijer GA, Geijtenbeek TB, van Kooyk Y. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 2005;65:5935-44.
178. Kaltner H, Stierstorfer B. Animal lectins as cell adhesion molecules. Acta Anat. 1998;161:162-79.
179. Lee RT, Lee YC. Neoglycoconjugates. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 55-77.
180. Rogers JC, Kornfeld S. Hepatic uptake of proteins coupled to fetuin glycopeptide. Biochem Biophys Res Commun. 1971;45:622-9.
181. André S, Frisch B, Kaltner H, Desouza DL, Schuber F, Gabius H-J. Lectin-mediated drug targeting. Selection of valency, sugar type (Gal/Lac) and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins. Pharmaceut Res. 2000;17:985-90.
182. Allavena P, Chieppa M, Monti P, Piemonti L. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol. 2004;24:179-92.
183. Taylor PR, Gordon S, Martinez-Pomares L. The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 2005;26:104-10.
184. Simpson DZ, Hitchen PG, Elmhirst EL, Taylor ME. Multiple interactions between pituitary hormones and the mannose receptor. Biochem J. 1999;343:403-11.
185. Fritz J, Katopodis AG, Kolbinger F, Anselmetti D. Force-mediated kinetics of single P-selectin/ligand complexes observed by atomic force microscopy. Proc Natl Acad Sci U S A. 1998;95:12283-8.
186. Dettmann W, Grandbois M, André S, Benoit M, Wehle AK, Kaltner H, Gabius H-J, Gaub HE. Differences in zero-force and force-driven kinetics of ligand dissociation from β-galactoside-specific proteins (plant and animal lectins, immunoglobulin G) monitored by plasmon resonance and dynamic single molecule force microscopy. Arch Biochem Biophys. 2000;383:157-70.
187. McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol. 2002;14:581-6.
188. Tees DFJ, Goetz DJ. Leukocyte adhesion: an exquisite balance of hydrodynamic and molecular forces. News Physiol Sci. 2003;18:186-90.
189. 2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med. 2001;194:1661-73.
190. Iozzo RV, Murdoch AD. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 1996;10:598-614.
191. Aspberg A, Miura R, Bourdoulous S, Shimonaka M, Heinegård D, Schachner M, Ruoslahti E, Yamaguchi Y. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci U S A. 1997;94:10116-21.
192. Aspberg A, Adam S, Kostka G, Timpl R, Heinegård D. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem. 1999;274:20444-9.
193. Lundell A, Olin AI, Mörgelin M, al-Karadaghi S, Aspberg A, Logan DT. Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure. 2004;12:1495-1506.
194. Gabius H-J. Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften. 2000;87:108-21.
195. Teichberg VI, Silman I, Beitsch DD, Resheff G. A β-D-galactoside binding protein from electric organ tissue of Electrophorus dectricus. Proc Natl Acad Sci U S A. 1975;72:1383-7.
196. Zeng F-Y, Gabius H-J. Sialic acid-binding proteins: characterization, biological functions and application. Z Naturforsch. 1992;47c:641-53.
197. Wu AM, Wu JH, Tsai M-S, Kaltner H, Gabius H-J. Carbohydrate specificity of a galectin from chicken liver (CG-16). Biochem J. 2001;358:529-38.
198. Wu AM, Wu JH, Tsai M-S, Liu J-H, André S, Wasano K, Kaltner H, Gabius H-J. Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochem J. 2002;367:653-64.
199. Pelletier I, Hashidate T, Urashima T, Nishi N, Nakamura T, Futai M, Arata Y, Kasai K-I, Hirashima M, Hirabayashi J, Sato S. Specific recognition of Leishmania major poly-β-galactosyl epitopes by galectin-9. Possible implication of galectin-9 in interaction between L. major and host cells. J Biol Chem. 2003;278:22223-30.
200. Van den Berg TK, Honing H, Franke N, van Remoortere A, Schiphorst WECM, Liu F-T, Deelder AM, Cummings RD, Hokke CH, van Die I. LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J Immunol-. 2004;173:1902-7.
201. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004;22:129-56.
202. Wu AM, Wu JH, Liu J-H, Singh T, André S, Kaltner H, Gabius H-J. Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galb1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie. 2004;86:317-26.
203. Ideo H, Seko A, Yamashita K. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem. 2005;280:4730-7.
204. Kawashima H, Watanabe N, Hirose M, Sun X, Atarashi K, Kimura T, Shikata K, Matsuda M, Ogawa D, Heljasvaara R, Rehn M, Pihlajaniemi T, Miyasaka M. Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J Biol Chem. 2003;278:13069-76.
205. Celie JWAM, Keuning ED, Beelen RHJ, Dräger AM, Zweegman S, Kessler FL, Soininen R, van den Born J. Identification of L-selectin binding heparan sulfates attached to collagen type XVIII. J Biol Chem. 2005;280:26965-73.
206. Wang L, Fuster M, Sriramarao P, Esko JD. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol. 2005;6:902-10.
207. Delacour D, Gouyer V, Zanetta J-P, Drobecq H, Leteurtre E, Grard G, Moreau-Hannedouche O, Maes E, Pons A, André S, Le Bivic A, Gabius H-J, Manninen A, Simons K, Huet G. Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J Cell Biol. 2005;169:491-501.
208. He L, André S, Siebert H-C, Helmholz H, Niemeyer B, Gabius H-J. Detection of ligand- and solvent-induced shape alterations of cell-growth-regulatory human lectin galectin-1 in solution by small angle neutron and X-ray scattering. Biophys J. 2003;85:511-24.
209. López-Lucendo MF, Solís D, André S, Hirabayashi J, Kasai K-I, Kaltner H, Gabius H-J, Romero A. Growth-regulatory human galectin-1: crystallographic characterization of structural changes induced by single-site mutations and their impact on thermodynamics of ligand binding increasing entropie penalty. J Mol Biol. 2004;343:957-70.
210. Vasudevan SV, Balaji PV. Molecular dynamics simulations of α2,8-linked disialoside: conformational analysis and implications for binding to proteins. Biopolymers. 2002;63:168-80.
211. Siebert H-C, Rosen J, Seyrek K, Kaltner H, André S, Bovin NV, Nyholm P-G, Sinowatz F, Gabius H-J. α2,3/αc2,6-Sialylation of N-glycans: non-synonymous signals with marked developmental regulation in bovine reproductive tracts. Biochimie. In press 2006.
212. 1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem. 1998;273:11205-11.
213. 1 versus bacterial toxins. Biochemistry. 2003;42:14762-73.
214. Merritt EA, Sarfaty S, Jobling MG, Chang T, Holmes RK, Hirst TR, Hol WG. Structural studies of receptor binding by cholera toxin mutants. Protein Sci. 1997;6:1516-28.
215. Campbell C, Stanley P. A dominant mutation to ricin resistance in Chinese hamster ovary cells induces UDP-GlcNAc:glycopeptide β-4-N- acetylglucosaminyltransferase III activity. J Biol Chem. 1984;259:13370-8.
216. Yamamoto H, Swoger J, Greene S, Saito T, Hurh J, Sweeley C, Leestma J, Mkrdichian E, Cerullo L, Nishikawa A, Ihara Y, Taniguchi N, Moskal JR. β1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res. 2000;60:134-42.
217. André S, Unverzagt C, Kojima S, Frank M, Seifert J, Fink C, Kayser K, von der Lieth C-W, Gabius H-J. Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. Eur J Biochem. 2004;271:118-34.
218. André S, Unverzagt C, Kojima S, Dong X, Fink C, Kayser K, Gabius H-J. Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its α2,3/α2,6-sialylated derivatives: their preparation, the assessment of their ligand properties for purified lectins, for tumor cells in vitro and in tissue sections and their biodistribution in tumor-bearing mice. Bioconjugate Chem. 1997;8:845-55.
219. Unverzagt C, André S, Seifert J, Kojima S, Fink C, Srikrishna G, Freeze H, Kayser K, Gabius H-J. Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional α2,3/α2,6-sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J Med Chem. 2002;45:478-91.
220. André S, Kojima S, Prahl I, Lensch M, Unverzagt C, Gabius H-J. Introduction of extended LEC14-type branching into core-fucosylated biantennary N-glycan: glycoengineering for enhanced cell binding and serum clearance of the neoglycoprotein. FEBS J. 2005;272:1986-98.
221. Rice KG, Weisz OA, Barthel T, Lee RT, Lee YC. Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat hepatocytes. J Biol Chem. 1990;265:18429-34.
222. Rice KG, Lee YC. Oligosaccharide valency and conformations in determining binding to the asialoglycoprotein receptor of rat hepatocytes. Adv Enzymol. 1993;66:41-83.
223. Rice KG, Wu P, Brand L, Lee YC. Interterminal distance and flexibility of a triantennary glycopeptide as measured by resonance energy transfer. Biochemistry. 1991;30:6646-55.
224. Wu P, Rice KG, Brand L, Lee YC. Differential flexibilities in three branches of an N-linked triantennary glycopeptide. Proc Natl Acad Sci U S A. 1991;88:9355-9.
225. Rice KG, Wu P, Brand L, Lee YC. Modification of oligosaccharide antenna flexibility induced by exoglycosidase trimming. Biochemistry. 1993;32:7264-70.
226. Stubbs HJ, Lih JJ, Gustafson TL, Rice KG. Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry. 1996;35:937-47.
227. Wu P, Lee KB, Lee YC, Brand L. Solution conformations of a biantennary glycopeptide and a series of its exoglycosidase products from sequential trimming of sugar residues. J Biol Chem. 1996;271:1470-4.
228. Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem. 1984;259:10834-40.
229. Joziasse DH, Schiphorst WECM, van den Eijnden DH, van Kuik JA, van Halbeek H, Vliegenthart JFG. Branch specificity of bovine colostrum CMP-sialic acid: Galβ1-4GlcNAc-R α2-6-sialyltransferase. Sialylation of bi-, tri-, and tetraantennary oligosaccharides and glycopeptides of the N-acetyllactosamine type. J Biol Chem. 1987;262:2025-33.
230. Ujita M, McAuliffe J, Hindsgaul O, Sasaki K, Fukuda MN, Fukuda M. Poly-N-acetyllactosamine synthesis in branched N-glycans is controlled by complemental branch specificity of i-extension enzyme and β1,4- galactosyltransferase I. J Biol Chem. 1999;274:16717-26.
231. Seko A, Yamashita K. Characterization of a novel galactose β1,3-N-acetylglucosaminyltransferase (β3Gn-T8): the complex formation of β3Gn-T2 and β3Gn-T8 enhances enzymatic activity. Glycobiology. 2005;15:943-51.
232. Hiraoka N, Kawashima H, Petryniak B, Nakayama J, Mitoma J, Marth JD, Lowe JB, Fukuda M. Core 2 branching β1,6-N-acetylglucosaminyltransferase and high endothelial venule-restricted sulfotransferase collaboratively control lymphocyte homing. J Biol Chem. 2004;279:3058-67.
233. Daniels MA, Hogquist KA, Stephen CJ. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol. 2002;3:903-10.
234. Endharti AT, Zhou YW, Nakashima I, Suzuki H. Galectin-1 supports survival of naive T cells without promoting cell proliferation. Eur J Immunol. 2005;35:86-97.
235. André S, Cejas Ortega PJ, Alamino Perez M, Roy R, Gabius H-J. Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. Glycobiology. 1999;9:1253-61.
236. André S, Pieters RJ, Vrasidas I, Kaltner H, Kuwabara I, Liu F-T, Liskamp RMJ, Gabius H-J. Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to various glycoproteins, lactose maxiclusters and cell surface glycoconjugates. ChemBioChem. 2001;2:822-30.
237. Dam TK, Brewer CF. Thermodynamic studies of lectin-carbohydrate interactions by isothermal titration calorimetry. Chem Rev. 2002;102:387-429.
238. Roy R. A decade of glycodendrimer chemistry. Trends Glycosci Glycotechnol. 2003;15:291-310.
239. André S, Kaltner H, Furuike T, Nishimura S-I, Gabius H-J. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjugate Chem. 2004;15:87-98.
240. Dam TK, Gabius H-J, André S, Kaltner H, Lensch M, Brewer CF. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry. 2005;44:12564-71.
241. Powell LD, Varki A. The oligosaccharide binding specificities of CD22b, a sialic acid-specific lectin of B cells. J Biol Chem. 1994;169:10628-36.
242. Solís D, Feizi T, Yuen CT, Lawson AM, Harrison RA, Loveless RW. Differential recognition by conglutinin and mannan-binding protein of N-glycans presented on neoglycolipids and glycoproteins with special reference to complement glycoprotein C3 and ribonuclease B. J Biol Chem. 1994;269:11555-62.
243. Hanasaki K, Powell LD, Varki A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. J Biol Chem. 1995;270:7543-50.
244. Moorman F, Barrett-Bergshoeff MM, Rijken DC. Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor. Eur J Biochem. 1998;251:107-13.
245. M. Glycobiology. 2003;13:755-63.
246. 1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem. 2005;280:37266-77.
247. Van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med. 2005;201:1281-92.
248. Edberg JC, Kimberly RP. Cell type-specific glycoforms of FcγRIIIa (CD16): differential ligand binding. J Immunol. 1997;159:3849-57.
249. Rabinovich GA, Rubinstein N, Toscano M. Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta. 2002;1572:274-84.
250. Dennis JW, Pawling J, Cheung P, Partridge E, Demetriou M. UDP-N-acetylglucosamine: α-6-D-mannoside β1,6 N- acetylglucosaminyltransferase V (Mgat5) deficient mice. Biochim Biophys Acta. 2002;1573:414-22.
251. Hakomori S-I. The glycosynapse. Proc Natl Acad Sci U S A. 2002;99:225-32.
252. Roth J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev. 2002;102:285-303.
253. Schrag JD, Procopio DO, Cygler M, Thomas DY, Bergeron JJ. Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem Sci. 2003;28:49-57.
254. Yoshida Y. A novel role for N-glycans in the ERAD system. J Biochem. 2003;134:183-90.
255. Helenius A, Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem. 2004;73:1019-49.
256. Lederkremer GZ, Glickman MH. A window of opportunity: timing protein degradation by trimming of sugars and ubiquitins. Trends Biochem Sci. 2005;30:297-303.
257. Mizushima T, Hirao T, Yoshida Y, Lee SJ, Chiba T, Iwai K, Yamaguchi Y, Kato K, Tsukihara T, Tanaka K. Structural basis of sugar-recognizing ubiquitin ligase. Nat Struct Mol Biol. 2004;11:365-70.
258. Hagihara S, Totani K, Matsuo I, Ito Y. Thermodynamic analysis oi interactions between N-linked sugar chains and F-box protein Fbs1. J Med Chem. 2005;48:3126-9.
259. Yoshida Y, Adachi E, Fukiya K, Iwai K, Tanaka K. Glycoprotein-specific ubiquitin ligases recognize N-glycans in unfolded substrates. EMBO Rep. 2005;6:239-44.
260. Cabral CM, Liu Y, Sifers RN. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem Sci. 2001;26:619-24.
261. Hebert DN, Garman SC, Molinari M. The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 2005;15:364-70.
262. Curtis BM, Scharnowske S, Watson AJ. Sequence and expression oi a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1992;89:8356-60.
263. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, Grabovsky V, Alon R, Figdor CG, van Kooyk Y. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol. 2000;1:353-7.
264. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575-85.
265. Koppel EA, van Gisbergen KP, Geijtenbeek TB, van Kooyk Y. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell Microbiol. 2005;7:157-65.
266. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med. 2003;197:1119-24.
267. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med. 2003;197:1107-17.
268. Adachi Y, Ishii T, Ikeda Y, Hoshino A, Tamura H, Aketagawa J, Tanaka S, Ohno N. Characterization of ß-glucan recognition site on C-type lectin, dectin 1. Infect Immun. 2004;72:4159-71.
269. Herre J, Willment JA, Gordon S, Brown GD. The role of dectin-1 in antifungal immunity. Crit Rev Immunol. 2004;24:193-203.
270. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD, Reis E Sousa C. Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity. 2005;22:507-17.
271. Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S, Brown GD. The human β-glucan receptor is widely expressed and functionally equivalent to murine dectin-1 on primary cells. Eur J Immunol. 2005;35:1539-47.
272. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R III, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR, Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem. 2000;275:20157-67.
273. Gabius H-J. Non-carbohydrate binding partners/domains of animal lectins. Int J Biochem. 1994;26:469-77.
274. Fukuda MN, Ohyama C, Lowitz K, Matsuo O, Pasqualini R, Ruoslahti E, Fukuda M. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res. 2000;60:450-6.
275. Ravindranath RM, Tam WY, Nguyen P, Fincham AG. The enamel protein amelogenin binds to the N-acetyl-D-glucosamine-mimicking peptide motif of cytokeratins. J Biol Chem. 2000;275:39654-61.
276. Montalto MC, Collard CD, Buras JA, Reenstra WR, McClaine R, Gies DR, Rother RP, Stahl GL. A keratin peptide inhibits mannose-binding lectin. J Immunol. 2001;166:4148-53.
277. Appeldoorn CCM, Molenaar TJM, Bonnefoy A, van Leeuwen SH, Vandervoort PA, Hoylaerts MF, van Berkel TJ, Biessen EA. Rational optimization of a short human P-selectin-binding peptide leads to nanomolar affinity antagonists. J Biol Chem. 2003;278:10201-7.
278. Rotblat B, Niv H, André S, Kaltner H, Gabius H-J, Kloog Y. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res. 2004;64:3112-8.
279. Wang JL, Gray RM, Haudek KC, Patterson RJ. Nucleocytoplasmic lectins. Biochim Biophys Acta. 2004;1673:75-93.
280. André S, Arnusch CJ, Kuwabara I, Russwurm R, Kaltner H, Gabius H-J, Pieters RJ. Identification of peptide ligands for malignancy- and growth-regulating galectins using random phage-display and designed peptide libraries. BioorgMed Chem. 2005;13:563-73.
281. Villalobo A, Nogales-Gonzalés A, Gabius H-J. A guide to signaling pathways connecting protein-glycan interaction with the emerging verstile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol. In press 2006.
282. White TK, Zhu Q, Tanzer ML. Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading. J Biol Chem. 1995;270:15926-8.
283. Tutuncu L, Stein P, Ord TS, Jorgez CJ, Williams CJ. Calreticulin on the mouse egg surface mediates transmembrane signaling linked to cell cycle resumption. Dev Biol. 2004;270:246-60.
284. Drew JE, Rucklidge GJ, Duncan G, Lufty A, Farquharson AJ, Reid MD, Russell WR, Morrice PC, Arthur JR, Duthie GG. A proteomics approach to identify changes in protein profiles in pre-cancerous colon. Biochem Biophys Res Commun. 2005;330:81-7.
285. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol. 2005;23:901-44.
286. Elad-Sfadia G, Haklai R, Ballan E, Gabius H-J, Kloog Y. Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J Biol Chem. 2002;277:37169-75.
287. Prior IA, Muncke C, Parton RG, Hancock JF. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol. 2003;160:165-70.
288. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med. 2000;192:1797-808.
289. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem. 2000;275:22442-51.
290. Gabius H-J, Springer WR, Barondes SH. Receptor for the cell binding site of discoidin I. Cell. 1985;42:449-56.
291. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3. J Immunol. 1996;156:1235-46.
292. Hoffmeister KM, Josefsson EC, Isaac NA, Clausen H, Hartwig JH, Stossel TP. Glycosylation restores survival of chilled blood platelets. Science. 2003;301:1531-4.
293. M lectin domain mediates the phagocytosis of chilled platelets. J Biol Chem. 2005;280:18025-32.
294. Jeffery CJ. Multifunctional proteins: examples of gene sharing. Ann Med. 2003;35:28-35.
295. Ganesh S, Tsurutani N, Suzuki T, Hoshii Y, Ishihara T, Delgado-Escueta AV, Yamakawa K. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem Biophys Res Commun. 2004;313:1101-9.
296. Wang W, Roach PJ. Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase. Biochem Biophys Res Commun. 2004;325:726-30.
297. Trainotti L, Spinello R, Piovan A, Spolaore S, Casadoro G. β-Galactosidases with a lectin-like domain are expressed in strawberry. J Exp Bot. 2001;361:1635-45.
298. Kanazawa N, Tashiro K, Miyachi Y. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Immunobiology. 2004;209:179-90.
299. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, Wirth H-P, Kapsenberg ML, Vandenbroucke-Grauls CMJE, van Kooyk Y, Appelmelk BJ. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med. 2004;200:979-90.
300. Morris ER, Walker JC. Receptor-like protein kinases: the keys to response. Curr Opin Plant Biol. 2003;6:339-42.
301. André S, Siebert H-C, Nishiguchi M, Tazaki K, Gabius H-J. Evidence for lectin activity of a plant receptor-like protein kinase by application of neoglycoproteins and bioinformatic algorithms. Biochim Biophys Acta. 2005;1725:222-32.
302. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11-22.
303. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71-8.
304. Ichim CV. Revisiting immunosurveillance and immunostimulation: implications for cancer immunotherapy. J Transl Med. 2005;3:8.
305. Kunze E, Schulz H, Adamek M, Gabius H-J. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response. J Cancer Res Clin Oncol. 2000;126:125-38.
306. Gabius H-J. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1. Biochimie. 2001;83:659-66.
307. Gabius H-J, Darro F, Remmelink M, André S, Kopitz J, Danguy A, Gabius S, Salmon I, Kiss R. Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Cancer Invest. 2001;19:114-26.
308. Timoshenko AV, Lan Y, Gabius H-J, Lala PK. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination: effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer. 2001;37:1910-20.
309. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JPM, Schroen B, André S, Crijns HJGM, Gabius H-J, Maessen J, Pinto YM. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004;110:3121-8.
310. Ozaki K, Tanaka T. Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci. 2005;62:1804-13.
311. Roseman S. Reflections on glycobiology. J Biol Chem. 2001;276:41527-42.
312. Montreuil J. The history of glycoprotein research, a personal view. In: Montreuil J, Vliegenthart JFG, Schachter H, editors. Glycoproteins. Amsterdam: Elsevier; 1995. p. 1-12.
313. Hounsell EF. Methods of glycoconjugate analysis. In: Gabius H-J, Gabius S, editors. Glycosciences: status and perspectives. London (UK)/Weinheim (Germany): Chapman & Hall; 1997. p. 15-29.
314. Geyer H, Geyer R. Strategies for glycoconjugate analysis. Acta Anat. 1998;161:18-35.
315. Luo Y, Haltiwanger RS. O-Fucosylation of Notch occurs in the endoplasmic reticulum. J Biol Chem. 2005;280:11289-94.
316. Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161-73.
317. Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705-12.
318. Montreuil J, Vliegenthart JFG, Schachter H, editors. Glycoproteins and disease. Amsterdam: Elsevier; 1996.
319. Jaeken J, Matthijs G. Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet. 2001;2:129-51.
320. Endo T, Toda T. Glycosylation in congenital muscular dystrophies. Biol Pharm Bull. 2003;26:1641-7.
321. Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr. 2003;162:359-79.
322. Michele DE, Campbell KP. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem. 2003;278:15457-60.
323. Gabius H-J, Engelhardt R, Cramer F. Endogenous tumor lectins: a new class of tumor markers and targets for therapy? Med Hypotheses. 1985;18:47-50.
324. Gabius H-J. Endogenous lectins in tumors and the immune system. Cancer Investig. 1987;5:39-46.
325. Ulbrich H, Eriksson EE, Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci. 2003;24:640-7.
326. Schön MP, Zollner TM, Boehncke W-H. The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. J Invest Dermatol. 2003;121:951-62.
327. Hutson AM, Atmar RL, Estes MK. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 2004;12:279-87.
328. Olofsson S, Bergström T. Glycoconjugate glycans as viral receptors. Ann Med. 2005;37:154-72.
329. Das SK, Mallet J-M, Esnault J, Driguez P-A, Duchaussoy P, Sizun P, Hérault J-P, Herbert J-M, Petitou M, Sinay P. Synthese konformativ fixierter Kohlenhydrate: eine Skew-Boot-Konformation der L-Iduronsäure in Heparin bestimmt dessen antithrombotische Aktivität. Angew Chem. 2001;113:1723-6.
330. Hricovíni M, Guerrini M, Bisio A, Torri G, Naggi A, Casu B. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution. Semin Thromb Hemost. 2002;28:325-34.